Dr. Davis has over 25 years of extensive experience leading the development, approvals, and launches of small molecules, biologics and devices. Dr. Davis is currently the Chief Medical Officer of Neuvivo.  Prior, he was the Chief Operating Officer and Chief Medical Officer at Tiziana Life Sciences, whose lead asset modulated the innate immune system.  In his career, Dr. Davis has served as Chief Medical Officer of several multinational pharmaceutical companies including Endo Pharmaceuticals. At URL Pharma he spearheaded three NDA approvals and was the inventor on all 17 Orange Book listed patents for Colcrys®. He was instrumental in the sale of URL Pharma to Takeda for over $2B including performance-based contingent earnout payments.

 

Dr. Davis matriculated to the University of Pennsylvania as an undergraduate. He received his Pharmacy Degree from Temple University and his Medical Degree from the Medical College of Pennsylvania. Dr. Davis undertook his surgical training at Brown University and his Urology training at Washington Hospital Center.